Galectin Therapeutics | GALT - L'Utile Operativo

Prezzo Delle Azioni
2.17
Cambio Giornaliero
-0.18 -7.66%
Mensile
-3.98%
Annuale
69.53%
Q2 Previsione
2.06




L'Utile Operativo Cambiamento Data
AbbVie USD 4.73B 1.08B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Galectin Therapeutics USD -11.29M 1.64M 2024-06
Gilead Sciences USD 2.68B 284M 2026-03
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 324.17M 59.7M 2026-03
Merck USD -1.88B 8.12B 2026-03